Replies to post #4954 on VistaGen Therapeutics Inc (VTGN)

[retireat40]

“Since June 30, 2023 and through August 10, 2023, the Company sold and settled an aggregate of 1,487,293 shares of common stock under its Sales Agreement with Jefferies and received gross cash proceeds of $16,893,700. Additional sales of 1,965,940 shares under the Sales Agreement are expected to settle on or before August 14, 2023, subject to customary settlement procedures, for expected gross cash proceeds of $15,172,023.”

[retireat40]

As of August 10, 2023, the Company had 9,362,444 shares of common stock outstanding.